IgG <i>N-</i>glycosylation from Patients with Pemphigus Treated with Rituximab

IgG <i>N-</i>glycosylation from Patients with Pemphigus Treated with Rituximab

Pemphigus is a life-threatening auto-immune blistering disease of the skin and mucous membrane that is caused by the production of auto-antibodies (auto-Abs) directed against adhesion proteins: desmoglein 1 and 3. We demonstrated in the “Ritux3” trial, the high efficacy of rituximab, an anti-CD20 re...

Full description

Bibliographic Details
Main Authors: Guillaume Font, Marie-Laure Walet-Balieu, Marie Petit, Carole Burel, Maud Maho-Vaillant, Vivien Hébert, Philippe Chan, Manuel Fréret, Olivier Boyer, Pascal Joly, Sébastien Calbo, Muriel Bardor, Marie-Laure Golinski
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Biomedicines
Subjects:
pemphigus
rituximab
IgG
glycosylation
<i>N</i>-glycome
<i>N</i>-glycans
Online Access:https://www.mdpi.com/2227-9059/10/8/1774

Internet

https://www.mdpi.com/2227-9059/10/8/1774

Similar Items